date/time interval
- October 16, 2024 - January 15, 2027
EndoMAP: A Phase IB/II Multi-Cohort Study of Targeted Agents and/or Immunotherapy with Atezolizumab forPatients with Recurrent or Persistent Endometrial Cancer
Grant
Overview
awarded by
administered by
sponsor award ID
- MCVF 242656-01
Affiliation
contributor
- Cantillo, Evelyn Principal Investigator (Subaward) 2024 - 2027